Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 188 publications
Correction: Utility of Multi‑Analyte Protein Assay to Distinguish Multiple Sclerosis Clinical Relapse from Pseudoexacerbation.
Journal: Neurology and therapy
Published: August 14, 2026
Induced pluripotent stem cell treatment for microglia replacement in progressive MS.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 21, 2026
NSAID use is associated with lower dementia and Alzheimer's disease prevalence and slower cognitive decline: A retrospective longitudinal analysis of the NACC cohort.
Journal: medRxiv : the preprint server for health sciences
Published: July 10, 2026
Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 07, 2026
Evolving MS criteria and the interpretation of research.
Journal: Therapeutic advances in neurological disorders
Published: June 29, 2026
Dynamics of Spinal Fluid Immune Cell Alterations Following Cladribine Tablet Treatment in Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: April 16, 2026
Clinical and radiological outcomes of directed treatment transitions from Gilenya® to generic fingolimod.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: January 03, 2026
Beyond the Single-Disease Paradigm-Why Distinctions in Multiple Sclerosis Still Matter.
Journal: JAMA neurology
Published: December 29, 2025
Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial.
Journal: Neurology
Published: December 15, 2025
Remyelination therapies are achievable in clinical practice-No.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 05, 2025
Glucagon‑like peptide‑1 receptor agonists in multiple sclerosis: therapeutic promise, challenges, and future directions.
Journal: Expert opinion on investigational drugs
Published: November 06, 2025
Last Updated: 09/26/2026